Help

DNAFORM Search Engine

Vector: pENTR221Source: ORFCollection: OCAADownload PDF Document
NAME: pENTR221
RESISTANT MARKER: Kanamycin resistant; 10 µg/ml
SOURCE: Invitrogen Life Technologies
V_TYPE: Gateway entry vector
SEQUENCING PRIMERS: M13(-21), M13 reverse
POLYLINKER SEQUENCE:
cgacaaacaacagataaaacgaaaggcccagtcttccgactgagcctttc
gttttatttgatgcctggcagttccctactctcgcgttaacgctagcatg
gatgttttcccagtcacgacgttgtaaaacgacggccagtcttaagctcg
ggccccaaataatgattttattttgactgatagtgacctgttcgttgcaa
caaattgatgagcaatgcttttttataatgccaactttgtacaaaaaagc
aggct-LINKER-ORF-LINKER-acccagctttcttgtacaaagttggc
attataagaaagcattgcttatcaatttgttgcaacgaacaggtcactat
cagtcaaaataaaatcattatttgccatccagctgatatcccctatagtg
agtcgtattacatggtcatagctgtttcctggcagctctggcccgtgtct
caaaatctctgatgttacattgcacaagataaaaatatatcatcatgaac
aataaaactgtctgcttacataaacagtaatacaaggggtgttatgagcc
atattcaacgggaaacgtcgaggccgcgattaaattcca

Note the specific antibiotic to be used with this vector.
Confirm sequencing primer sequences match vector before sequencing.

All ORF clones are provided in Entry Vectors for the Invitrogen Gateway®
cloning system. Invitrogen offers a whole range of Destination Vectors for
a wide range of applications. Refer to the homepage of Invitrogen for further
information on the GatewayR cloning system and related Invitrogen products at:
http://www.invitrogen.com/content.cfm?pageid=4072
For further information on the ORFeome Collaboration, visit their homepage at
http://www.orfeomecollaboration.org/html/index.shtml.
For further technical information visit our homepage at: http://www.dnaform.jp
or contact us under: techinfo@dnaform.jp.
1 ACATGTTCTT TCCTGCGTTA TCCCCTGATT CTGTGGATAA CCGTATTACC GCCTTTGAGT 60
61 GAGCTGATAC CGCTCGCCGC AGCCGAACGA CCGAGCGCAG CGAGTCAGTG AGCGAGGAAG 120
121 CGGAAGAGCG CCCAATACGC AAACCGCCTC TCCCCGCGCG TTGGCCGATT CATTAATGCA 180
181 GCTGGCACGA CAGGTTTCCC GACTGGAAAG CGGGCAGTGA GCGCAACGCA ATTAATACGC 240
241 GTACCGCTAG CCAGGAAGAG TTTGTAGAAA CGCAAAAAGG CCATCCGTCA GGATGGCCTT 300
301 CTGCTTAGTT TGATGCCTGG CAGTTTATGG CGGGCGTCCT GCCCGCCACC CTCCGGGCCG 360
361 TTGCTTCACA ACGTTCAAAT CCGCTCCCGG CGGATTTGTC CTACTCAGGA GAGCGTTCAC 420
421 CGACAAACAA CAGATAAAAC GAAAGGCCCA GTCTTCCGAC TGAGCCTTTC GTTTTATTTG 480
481 ATGCCTGGCA GTTCCCTACT CTCGCGTTAA CGCTAGCATG GATGTTTTCC CAGTCACGAC 540
541 GTTGTAAAAC GACGGCCAGT CTTAAGCTCG GGCCCCAAAT AATGATTTTA TTTTGACTGA 600
601 TAGTGACCTG TTCGTTGCAA CAAATTGATG AGCAATGCTT TTTTATAATG CCAACTTTGT 660
661 ACAAAAAAGC AGGCTACCCA GCTTTCTTGT ACAAAGTTGG CATTATAAGA AAGCATTGCT 720
721 TATCAATTTG TTGCAACGAA CAGGTCACTA TCAGTCAAAA TAAAATCATT ATTTGCCATC 780
781 CAGCTGATAT CCCCTATAGT GAGTCGTATT ACATGGTCAT AGCTGTTTCC TGGCAGCTCT 840
841 GGCCCGTGTC TCAAAATCTC TGATGTTACA TTGCACAAGA TAAAAATATA TCATCATGAA 900
901 CAATAAAACT GTCTGCTTAC ATAAACAGTA ATACAAGGGG TGTTATGAGC CATATTCAAC 960
961 GGGAAACGTC GAGGCCGCGA TTAAATTCCA ACATGGATGC TGATTTATAT GGGTATAAAT 1020
1021 GGGCTCGCGA TAATGTCGGG CAATCAGGTG CGACAATCTA TCGCTTGTAT GGGAAGCCCG 1080
1081 ATGCGCCAGA GTTGTTTCTG AAACATGGCA AAGGTAGCGT TGCCAATGAT GTTACAGATG 1140
1141 AGATGGTCAG ACTAAACTGG CTGACGGAAT TTATGCCTCT TCCGACCATC AAGCATTTTA 1200
1201 TCCGTACTCC TGATGATGCA TGGTTACTCA CCACTGCGAT CCCCGGAAAA ACAGCATTCC 1260
1261 AGGTATTAGA AGAATATCCT GATTCAGGTG AAAATATTGT TGATGCGCTG GCAGTGTTCC 1320
1321 TGCGCCGGTT GCATTCGATT CCTGTTTGTA ATTGTCCTTT TAACAGCGAT CGCGTATTTC 1380
1381 GTCTCGCTCA GGCGCAATCA CGAATGAATA ACGGTTTGGT TGATGCGAGT GATTTTGATG 1440
1441 ACGAGCGTAA TGGCTGGCCT GTTGAACAAG TCTGGAAAGA AATGCATAAA CTTTTGCCAT 1500
1501 TCTCACCGGA TTCAGTCGTC ACTCATGGTG ATTTCTCACT TGATAACCTT ATTTTTGACG 1560
1561 AGGGGAAATT AATAGGTTGT ATTGATGTTG GACGAGTCGG AATCGCAGAC CGATACCAGG 1620
1621 ATCTTGCCAT CCTATGGAAC TGCCTCGGTG AGTTTTCTCC TTCATTACAG AAACGGCTTT 1680
1681 TTCAAAAATA TGGTATTGAT AATCCTGATA TGAATAAATT GCAGTTTCAT TTGATGCTCG 1740
1741 ATGAGTTTTT CTAATCAGAA TTGGTTAATT GGTTGTAACA CTGGCAGAGC ATTACGCTGA 1800
1801 CTTGACGGGA CGGCGCAAGC TCATGACCAA AATCCCTTAA CGTGAGTTAC GCGTCGTTCC 1860
1861 ACTGAGCGTC AGACCCCGTA GAAAAGATCA AAGGATCTTC TTGAGATCCT TTTTTTCTGC 1920
1921 GCGTAATCTG CTGCTTGCAA ACAAAAAAAC CACCGCTACC AGCGGTGGTT TGTTTGCCGG 1980
1981 ATCAAGAGCT ACCAACTCTT TTTCCGAAGG TAACTGGCTT CAGCAGAGCG CAGATACCAA 2040
2041 ATACTGTCCT TCTAGTGTAG CCGTAGTTAG GCCACCACTT CAAGAACTCT GTAGCACCGC 2100
2101 CTACATACCT CGCTCTGCTA ATCCTGTTAC CAGTGGCTGC TGCCAGTGGC GATAAGTCGT 2160
2161 GTCTTACCGG GTTGGACTCA AGACGATAGT TACCGGATAA GGCGCAGCGG TCGGGCTGAA 2220
2221 CGGGGGGTTC GTGCACACAG CCCAGCTTGG AGCGAACGAC CTACACCGAA CTGAGATACC 2280
2281 TACAGCGTGA GCATTGAGAA AGCGCCACGC TTCCCGAAGG GAGAAAGGCG GACAGGTATC 2340
2341 CGGTAAGCGG CAGGGTCGGA ACAGGAGAGC GCACGAGGGA GCTTCCAGGG GGAAACGCCT 2400
2401 GGTATCTTTA TAGTCCTGTC GGGTTTCGCC ACCTCTGACT TGAGCGTCGA TTTTTGTGAT 2460
2461 GCTCGTCAGG GGGGCGGAGC CTATGGAAAA ACGCCAGCAA CGCGGCCTTT TTACGGTTCC 2520
2521 TGGCCTTTTG CTGGCCTTTT GCTC 2544


Home cDNA Library DeepCAGE Service Clone Distribution

Powered by Japan Bioinformatics K.K.